Use of a combination of morphine and at least one opiate antagonist for the treatment of opiate dependence and for the prevention of non-oral opiate abuse among opiate addicts

摘要

Use of delayed-release morphine (I) and at least one opiate antagonist (II) that lacks high bioavailability after oral administration for preparation of a non-intravenously administered pharmaceutical composition for treating drug addiction. ACTIVITY : Antiaddictive. No details of tests for antiaddictive activity are given. MECHANISM OF ACTION : Opiate substitution and antagonism.